The corrupt bureaucrats at the Food and Drug Administration have handed Communist China complete control over America's weight loss drug supply chain through a shadowy "Green List" system that prioritizes Chinese manufacturers over American safety, according to bombshell testimony from RX Border Defense's Patsy Writesman.
Speaking exclusively to Breitbart News, Writesman exposed how the FDA's reckless policies have allowed the Chinese Communist Party to corner the market on GLP-1 obesity drugs like Ozempic and Wegovy – medications that millions of Americans depend on for their health.
"The FDA has essentially surrendered our entire GLP-1 supply chain to China," Writesman revealed during a Washington event focused on the China threat. "This isn't just about economics – this is about national security and the safety of American patients."
Biden's FDA Put China First, Americans Last
The revelation comes as no surprise to patriots who watched the Biden regime systematically weaken America while empowering our greatest adversary. While everyday Americans struggled with obesity and diabetes, Biden's FDA was busy making it easier for Chinese companies to flood our market with their products.
This "Green List" system apparently fast-tracks approval for foreign manufacturers – with China being the primary beneficiary. Meanwhile, American pharmaceutical companies face endless red tape and regulatory hurdles that make it nearly impossible to compete.
"When you control the supply chain, you control the market. And when China controls both, American patients become pawns in the CCP's global chess game."
The implications are staggering. What happens when China decides to cut off our supply during a crisis? What safeguards exist to ensure these Chinese-manufactured drugs meet American safety standards?
Trump Administration Must Act NOW
This is exactly the kind of deep state corruption that President Trump was elected to root out. The American people deserve medications manufactured under strict American oversight, not whatever passes for quality control in Communist China.
It's time for the Trump administration to tear up this "Green List" and bring pharmaceutical manufacturing back to American soil. Our health – and our national security – depends on it.